Research reveals: The medicine is selected safely to resist the result of recuring of breast cancer
Research reveals: The medicine is selected safely to resist the result of recuring of breast cancer
A latest research that European researchers carry on reveals, select safe (Z o m e t a)s in resisting the osteoporosis medicine of Swiss Novartis Company Can reduce the recurring probability of the early breast cancer patient before entering climacteric 36. Select safe to contain pairs of the intersection of phosphate compound and thiazole, come on phosphoric acid, use for, treat the intersection of cancer and bone, shift originally. Say at the clinical tumour society's annual meeting of U.S.A. that European researchers hold in Chicago of U.S.A. on May 31, a result of large-scale research that they do reveals, selecting safely can prevent early breast cancer patient's cancer from recuring effectively. This is about selecting the safe large-scale medical research of item one against cancer performance. The research the intersection of El and doses of Nantes preside over by the intersection of Austrian and the intersection of rice and summer of University of Vienna. Researchers have investigated 1803 early breast cancer patients who accept hormone treatment, these patients all have no menopause when being ill. Researchers let these patients take while taking hormone medicine and select safely, find, select safe to recur, sure result produced preventing cancering from finally, efficient to reach 36. Dose of Nantes said, they are not still clear that select safely how to play a role in preventing breast carcinoma from recuring, perhaps it has prevented the cancer cell from growing, perhaps prevent the cancer cell from spreading, also probably played these two kinds of function at the same time. He says, selects safe" can serve as anticancer drug " ,Once there is small-scale research that must make the similar conclusion too in the past.
|
No comments:
Post a Comment